Synthonics

Innovating metal-coordinated pharmaceuticals to improve drug efficacy and patient outcomes

placeBlacksburg, Virginia, United States calendar_todayFounded 2006 groups4 employees language synthonicsinc.com

Registered entities

Innovation

11 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,525 times.

YearFilings
20135
20143
20151
20167
20174
20181
20191
20202
20212
20222
20231
20251

Investor mix

2 investors on record; lead investors include Recipharm.

Investor typeCountShare
Other / undisclosed2100%
Coming soon